This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
CO Telmisartan/HCT - 80 mg/12.5 mg
- Starting date:
- May 25, 2013
- Posting date:
- June 6, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Quality
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-33923
Recalled products
- CO Telmisartan/HCT - 80 mg/12.5 mg
Reason
Quality concerns at the manufacturing facility of the active ingredients used in the products.
Depth of distribution
Product distributed to wholesalers and pharmacies within Canada.
Affected products
A. CO Telmisartan/HCT - 80 mg/12.5 mg
DIN, NPN, DIN-HIM
DIN 02393263
Dosage form
- Tablets
Strength
- 80 mg / 12.5 mg
Lot or serial number
- 135625A
Companies
- Recalling Firm
-
Cobalt Pharmaceuticals Inc.
6500 Kitimat Road,
Mississauga
L5N 2B8
Ontario
CANADA
- Marketing Authorization Holder
-
Cobalt Pharmaceuticals Inc.
6500 Kitimat Road,
Mississauga
L5N 2B8
Ontario
CANADA